Download Current Topics in Heart Failure: Experimental and Clinical by Prof. Dr. R. Jacob (auth.), Prof. Dr. Rainer W. Gülch, Prof. PDF

By Prof. Dr. R. Jacob (auth.), Prof. Dr. Rainer W. Gülch, Prof. Dr. Gerolf Kissling (eds.)

Show description

Read or Download Current Topics in Heart Failure: Experimental and Clinical Aspects PDF

Similar clinical books

Dyslipidaemia in Clinical Practice, 2nd Edition

The second one version bargains the reader the very newest details on lipid problems from aetiology to the administration of this ever expanding challenge that may be a significant explanation for atherosclerotic and heart problems. Written by way of a health care professional, an epidemiologist, and a lipidologist, this concise and well-illustrated textual content will attract quite a lot of experts who're dealing more and more with dyslipidaemia.

Adenosine, Cardioprotection and Its Clinical Application

The sizeable progress within the variety of articles on adenosine cardioprotection lately has been comparable largely to the speculation that adenosine performs a job in ischemic preconditioning. Ischemic preconditioning is the phenomenon within which a quick interval of ischemia (and reperfusion) ahead of a extra lengthy occlusion reduces myocardial infarct measurement.

Etomidate: An Intravenous Hypnotic Agent First Report on Clinical and Experimental Experience

The query the best way to set off normal anaesthesia easily has been requested again and again by way of anaesthetists and pharmacologists. P. A. JANSSEN built etomidate and released this substance in 1971 as "a effective short-acting and comparatively atoxic intravenous hypnotic agent in rats". In 1974 after numerous years of experimental and medical trial the barbiturate-free hypnotic etomidate (soon advertised as Hypnomidate) was once brought to various auditors on the party of the IV.

Extra resources for Current Topics in Heart Failure: Experimental and Clinical Aspects

Example text

Circ Res 57:84-95 40. Pfeffer J, Pfeffer M, Braunwald E (1987) Hemodynamic benefits and prolonged survival with long-term captopril therapy in rats with myocardial infarction and heart failure. Circulation 75:1149-1155 41. Pfeffer MA, Pfeffer JM, Fishbein MC, Fletcher PJ, Spadaro J, Kloner RA, Braunwald E (1979) Myocardial infarct size and ventricular function in rats. Circ Res 44:503-512 42. Pfeffer JM, Pfeffer MA, Fletcher PJ, Braunwald E (1984) Ventricular performance in rats with myocardial infarction and failure.

Circ Res 59:256-261 50. Zimmer H-G, Martius PA, Marschner G (1989) Myocardial infarction in rats: effects of metabolic and pharmacologic interventions. Basic Res Cardiol84:332-343 Authors' address: Prof. Dr. Naranjan S. Dhalla Division of Cardiovascular Sciences St. Boniface General Hospital Research Centre 351 Tache Avenue Winnipeg, Manitoba Canada R2H 2A6 Myocardial fibrosis: role of ventricular systolic pressure, arterial hypertension, and circulating hormones * K. T. Weber, C. G. Brilla, J.

In addition, an electromagnetic flow probe was placed around the ascending aorta. The enddiastolic volume was derived from the end-diastolic pressure-volume relation which could be registered at the end of each experiment [for further details see (1, 15)]. Results and discussion The simplified interpretation that any chronic enlargement of the heart under unchanged end-diastolic wall stress is detrimental because of a reduction in stroke-volume due to higher wall stress can be refuted by measurements demonstrated in Fig.

Download PDF sample

Rated 4.76 of 5 – based on 30 votes

About admin